395 results in Exploration of Targeted Anti-tumor Therapy
Most Viewed
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer
Gerhard Hamilton ... Barbara Rath
Published: October 26, 2023 Explor Target Antitumor Ther. 2023;4:1027–1038
This article belongs to the special issue Integrated Approaches for Non-Small-Cell Lung Cancer
Open Access
Review
Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer
Kriti Das ... Chakresh Kumar Jain
Published: December 27, 2023 Explor Target Antitumor Ther. 2023;4:1286–1300
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Meta-Analysis
Shorter telomere length as a prognostic marker for survival and recurrence in breast cancer: a systematic review and meta-analysis
Dhyas Munandar Arya Sasmita ... Sumadi Lukman Anwar
Published: February 13, 2025 Explor Target Antitumor Ther. 2025;6:1002289
Open Access
Original Article
Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy
Witida Laopajon ... Watchara Kasinrerk
Published: December 06, 2023 Explor Target Antitumor Ther. 2023;4:1145–1156
This article belongs to the special issue Novel Strategies and Targets for Immunotherapy of Cancer
Open Access
Review
An introductory review of post-resection chemotherapeutics for primary brain tumors
Meaghan McGovern ... Brandon Lucke-Wold
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:537–544
Open Access
Review
Anticancer action of naturally occurring emodin for the controlling of cervical cancer
Priyanka S. Lande ... Leena P. Joge
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:690–698
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Review
Targeted therapy of multiple myeloma
Shan Zhou, Renxi Wang
Published: October 31, 2021 Explor Target Antitumor Ther. 2021;2:465–480
Open Access
Review
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen ... Fahima Dilnawaz
Published: April 10, 2025 Explor Target Antitumor Ther. 2025;6:1002308
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Perspective
Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors
Stefano Lucà ... Renato Franco
Published: May 21, 2024 Explor Target Antitumor Ther. 2024;5:465–476
This article belongs to the special issue Molecular Diagnosis and Personalized Therapy of Cancer
Open Access
Original Article
Deep learning based clinico-radiological model for paediatric brain tumor detection and subtype prediction
Abhishek Mahajan ... Aliasgar Moiyadi
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:669–684
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Open Access
Original Article
Investigations of the novel checkpoint kinase 1 inhibitor SRA737 in non-small cell lung cancer and colorectal cancer cells of differing tumour protein 53 gene status
Ali JN Duabil ... George DD Jones
Published: December 21, 2023 Explor Target Antitumor Ther. 2023;4:1210–1226
Open Access
Review
Cancer vaccines: advances, hurdles, and future directions
Panagiotis J. Vlachostergios
Published: November 24, 2025 Explor Target Antitumor Ther. 2025;6:1002350
This article belongs to the special issue Cancer Vaccines: From Basic Innovations to Clinical Translation
Open Access
Review
Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance
Tatiana Ruksha, Nadezhda Palkina
Published: June 05, 2025 Explor Target Antitumor Ther. 2025;6:1002322
Open Access
Perspective
Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
Sabah Alaklabi ... Shipra Gandhi
Published: December 27, 2023 Explor Target Antitumor Ther. 2023;4:1301–1309
This article belongs to the special issue Innovative Strategies to Target Triple-negative Breast Cancer
Open Access
Review
Nanomedicine strategies to counteract cancer stemness and chemoresistance
Huayu Liu ... Ran Mo
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:630–656
Open Access
Review
Exploring the therapeutic potential of lipid-based nanoparticles in the management of oral squamous cell carcinoma
Anis Ahmad Chaudhary ... Md. Rizwanullah
Published: September 29, 2024 Explor Target Antitumor Ther. 2024;5:1223–1246
Open Access
Systematic Review
Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field
Angela Barillaro ... Roberto Pacelli
Published: February 13, 2025 Explor Target Antitumor Ther. 2025;6:1002290
This article belongs to the special issue Use of Different Radiation Treatment Modalities in Cancer Therapy: The Role of Inflammation and Immune Response
Open Access
Perspective
Cholesterol esterification and p53-mediated tumor suppression
Youjun Li ... Edward V. Prochownik
Published: October 31, 2023 Explor Target Antitumor Ther. 2023;4:1122–1127
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
Open Access
Review
Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects
Rustam Nailevich Mustafin
Published: August 06, 2024 Explor Target Antitumor Ther. 2024;5:1011–1026
Open Access
Review
Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics
Serge Mignani ... Jean-Pierre Majoral
Published: February 25, 2022 Explor Target Antitumor Ther. 2022;3:50–61
This article belongs to the special issue Gene Delivery Approach to Fight Cancer
Previous